🔥Telegram İfşa

🆕️🔥 #JAC Linezolid brain penetration in neurointensive care patients 🔆Linezolid showed a high penetration into both CSF & cerebral interstitial fluid 🔆However, linezolid exposure in cerebral ISF was typically lower than in plasma and CSF #IDXposts academic.oup.com/jac/advance-ar…

Isavuconazole is first-line treatment of invasive aspergillosis 🆕️⚡️⚡️Retrospective analysis Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoring #IDXposts #TDM academic.oup.com/jac/article-ab…

📢 🔥EMA CHMP recommends a new antibiotic for approval Emblaveo (aztreonam-avibactam), indicated for treatment of cIAI, UTI,HAP & infections caused by certain types of bacteria that are resistant to other Abx & where patients have limited or no Rx options ema.europa.eu/en/news/meetin…

It’s time to demote vancomycin blogs.jwatch.org/hiv-id-observa…

Precision daptomycin dosing faces clinical implementation barriers despite known exposure-safety concerns w high dose! Wow! 🆕️🔥 Clinical Infectious Diseases with Amit Pai Revolutionizing Daptomycin Dosing: A Single 7-11 Hour Sample for Pragmatic Application academic.oup.com/cid/article/do…

#BreakingNews U.S. FDA approved Zevtera shows efficacy and marks a new treatment option for bacterial infections including MRSA. #FDAapproval contagionlive.com/view/fda-appro…

1/ This week in #IDTwitter Alice Han asked a great question about meropenem-resistant Strep pneumo. UNMC ID ASP recently had a similar question when looking at our antibiogram. So I did a mini-lit review in the form of a #Tweetorial /thread x.com/dralicehan/sta…

Infectious Disease Pharmacists Day! Today, May 22nd, honors SIDP and their dedication to improving patient care through antimicrobial stewardship. #IDPharmacistsDay #SIDPAdvocacy #JoinTheAMSFight contagionlive.com/clinical-corner

MAD-ID is proud to support #IDPharmacistsDay celebrating the impact ID Pharmacists have on their patients today and the future! #SIDPAdvocacy #JoinTheAMSFight SIDP

📣 Pharmacists are a growing presence in AMS programs in hospitals across the nation. 🏥 “The percentage of hospital [AMS] programs co-led by a physician and a pharmacist increased from 23% in 2015 to 64% in 2021.” #IDPharmacistsDay #JoinTheAMSFight buff.ly/4avlcFx

BLING-3 trial, oot now in JAMA jamanetwork.com/journals/jama/…

🔥 Just published 🔥 IDSA 2024 Guideline Update on the Risk Assessment, Diagnostic Imaging, and Microbiological Evaluation of Complicated Intra-abdominal Infections in Adults, Children, and Pregnant People #idxposts idsociety.org/practice-guide…

🔥FDA is announcing full approval of SIRTURO® Bedaquiline, a drug for pulmonary tuberculosis (TB) due to multi-drug resistant tuberculosis (MDR-TB), as part of a combination therapy for adults and pediatric patients🔥 View prescribing information: accessdata.fda.gov/drugsatfda_doc…

Just Accepted‼️ 👀Check out new pip/tazo STIC recommendations from our colleagues at USCAST! 🔗: doi.org/10.1093/cid/ci…

In order to address the challenges &shortcomings in the current (ie 2014)IDSA SSTI guidelines in terms of antibiotic stewardship 🆕️🔥 AJHP Antibiotic stewardship in the ED setting:Focus on oral antibiotic selection for adults with SSTI #IDXposts academic.oup.com/ajhp/advance-a…

NEW CDC report underscores #AntimicrobialResistance remains an urgent #PublicHealth threat. Check out the new data and share with others who are working to continue the fight against AR. bit.ly/ARThreats2022

📰 Extra! Extra! Read all about the 2024 updates to the IDSA Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections. Below are highlights from the Notable Updates from 2023 section. For more info: buff.ly/3WdrVyr #AntimicrobialResistance #IDTwitter

No Clinical Safety or Efficacy Issues Identified No Requirement for Further Clinical Data or Trials

Time to settle the debate over once vs twice daily dosing of ceftriaxone for community acquired bacterial meningitis in children. 🤔 is anyone planning on changing their practice especially with the #ivfluidshortage #ASP SHARPS group journals.asm.org/doi/10.1128/aa…

Happy ID Pharmacists day 🥳🥳‼️This year's theme is  "Innovation in ID: Pharmacists Leading the Way."  Please join the discussion on Bluesky with SIDP between 12-1 PM EST today 🦠🧫💊#IDPharmacistsDay, #SIDPAdvocacy, #FutureOfIDPharmacy, #PharmacistsLeadingChange, #IDXposts